 A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Non-inferiority, Phase III Study to Investigate the Efficacy Immunogenicity and Safety of GC3106 quadrivalent cell-culture based influenza vaccine after Intramuscular Administration in Healthy Subjects. 